A Phase 2 Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of SAL0150 Tablets in Subjects With Type 2 Diabetes Mellitus
Community vote
No Bro-Meter votes yet. Be the first. The verdict is only these votes — not FDA pages, imports, or ads.
Tried-it reports
Lived experience sits next to the community vote. Official sources never override either.
NOT_YET_RECRUITING · Shenzhen Salubris Pharmaceuticals Co., Ltd. Imported from ClinicalTrials.gov. This was filed by the system importer, not a fake user. Possible receipts (auto-attached from public APIs — verify before trusting): - ClinicalTrials.gov: A Phase 2 Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of SAL0150 Tablets in Subjects With Type 2 Diabetes Mellitus — https://clinicaltrials.gov/study/NCT07923357
Not medical advice. We don't sell peptides. Votes and comments are community opinion, not clinical guidance.
Comments
No comments yet. Got receipts? Drop them.